Synthesis and anticancer evaluation of 6-azacyclonol-2,4,6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer
作者:Ujjwala Karmacharya、Prakash Chaudhary、Dongchul Lim、Sadan Dahal、Bhuwan Prasad Awasthi、Hee Dong Park、Jung-Ae Kim、Byeong-Seon Jeong
DOI:10.1016/j.bioorg.2021.104805
日期:2021.5
3A showed better activity than 3J. Antitumor activity of compound 3A was also observed in DU145-xenografted chorioallantoic membrane (CAM) tumor model. In addition, the ligand-based target prediction and molecular docking study using DeepZema® server showed compound 3A was a ligand to M3 muscarinic acetylcholine receptor (M3R) which is overexpressed in ARPC. Carbachol, a muscarinic receptor agonist
我们最近报道了 2,4,5-trimethylpyridin-3-ol 和 C(6)-azacyclonol,其代号为 BJ-1207,通过抑制 A549 人肺癌细胞中 NOX 衍生的 ROS 显示出有希望的抗癌活性。本研究的重点是对 BJ-1207 的氮杂环醇部分进行结构修饰,以寻找具有更好抗癌活性的化合物。制备了 10 种新化合物 ( 3A – 3J),并评估了它们对 18 种癌细胞系增殖的抑制作用,作为初步筛选。在BJ-1207的10种衍生物中,化合物3A和3J对DU145和PC-3、雄激素难治性癌细胞系(ARPC)的影响大于母体化合物和化合物3A显示出比3J更好的活性。在 DU145 异种移植绒毛膜尿囊膜 (CAM) 肿瘤模型中也观察到化合物3A 的抗肿瘤活性。此外,使用 DeepZema® 服务器进行的基于配体的靶标预测和分子对接研究表明,化合物3A是 M3 毒蕈碱乙酰胆碱受体 (M3R)